Cubist Systematic Strategies’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-914,286
Closed -$810K 4784
2022
Q4
$810K Buy
914,286
+74,542
+9% +$98.9K 0.01% 2641
2022
Q3
$1.32M Buy
839,744
+10,665
+1% +$24.2K 0.01% 2380
2022
Q2
$1.67M Buy
829,079
+592,679
+251% +$1.02M 0.01% 2022
2022
Q1
$551K Buy
236,400
+220,209
+1,360% +$687K ﹤0.01% 2479
2021
Q4
$75K Buy
+16,191
New +$101K ﹤0.01% 3255
2021
Q3
Sell
-21,028
Closed -$204K 3272
2021
Q2
$204K Buy
+21,028
New +$167K ﹤0.01% 2555
2020
Q4
Sell
-28,335
Closed -$316K 2771
2020
Q3
$316K Sell
28,335
-296,265
-91% -$2.71M ﹤0.01% 1968
2020
Q2
$2.04M Buy
+324,600
New +$1.24M 0.04% 782
2015
Q3
Sell
-10,430
Closed -$184K 2066
2015
Q2
$184K Sell
10,430
-7,190
-41% -$92.4K 0.01% 1468
2015
Q1
$204K Buy
+17,620
New +$204K 0.01% 1521

Other funds holding SRNE